Baker Avenue Asset Management, LP Citius Pharmaceuticals, Inc. Transaction History
Baker Avenue Asset Management, LP
- $3.41 Billion
- Q3 2024
Shares
3 transactions
Others Institutions Holding CTXR
# of Institutions
67Shares Held
30.1MCall Options Held
24.7KPut Options Held
0-
Armistice Capital, LLC New York, NY10.2MShares$3.96 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$2.51 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.05MShares$799,0550.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$732,7910.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$704,2330.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $57M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...